MedTrace Logo

Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.

NCT02174328 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2019-04-26

No results posted yet for this study

Summary

The main objective of this trial is to study the occurrence of preeclampsia in recipients of donated oocytes receiving aspirin at an early stage during pregnancy and to compare the results with those obtained in patients receiving placebo.

Conditions

  • Pre-Eclampsia

Interventions

DRUG

Acetylsalicylic acid

Acetylsalicylic acid once a day until 36 week

DRUG

Placebo

Placebo once a day until 36 week

Sponsors & Collaborators

  • Instituto de Investigacion Sanitaria La Fe

    lead OTHER

Principal Investigators

  • Alfredo Perales, PhD · La Fe University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-21
Primary Completion
2018-04-20
Completion
2018-04-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02174328 on ClinicalTrials.gov